| 产品名称 | Peptides LB01951 | Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool |
|---|---|
| 目录号 | LB01951 |
| 别名 | Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| LB01951 | 15 nmol/peptide | 咨询 | 咨询 |
Peptides LB01951 | Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool
品名：Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool
货号：LB01951
规格：15 nmol/peptide
品牌：Peptides.de
产品描述
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2 which emerged in the US in March 2020. One unit allows the stimulation of 2,5 x 108 cells.
One unit allows the stimulation of 2,5 x 108 cells.
| Protein | Spike glycoprotein | UniProt Id | P0DTC2 |
| Species | SARS-CoV-2 | Gene | S |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | ||
| Indication | Infectious disease | ||
| Amount/Aliquote | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells | ||
